The EpiPen4Schools® program, offered by Mylan Specialty, the marketer and distributor of EpiPen® (epinephrine) and EpiPen Jr® (epinephrine)
Auto-Injectors, was developed to help improve access to epinephrine in the event a person experiences a life-threatening allergic reaction (anaphylaxis) in the school setting.
This access is important because epinephrine is the only first-line treatment for anaphylaxis. According to the food allergy guidelines developed by the
National Institute of Allergy and Infectious Diseases, if experiencing anaphylaxis, a person should use an epinephrine auto-injector and seek immedidate
emergency medical care. Carrying an epinephrine auto-injector does not prevent patients from having an anaphylactic reaction; hence, patients must avoid their
triggers at all times.
The program offers four FREE EpiPen or EpiPen Jr Auto-Injectors to qualifying public and private kindergarten, elementery, middle and high schools in the U.S.
Requirements to qualify for this offer include having a valid prescription. The products are available in the form of two EpiPen 2-Pak® cartons,
two EpiPen Jr 2-Pak® cartons or one 2-Pak of each kind. Each EpiPen 2-Pak contains two single auto-injectors, instructions for use and a training device,
with no drug product or needle, to help patients become familiar with the administration technique.
For more information on anaphylaxis or
EpiPen Auto-Injectors, visit epipen.com.